Will people with acute pain want a new painkiller whose list price is $15.50 a pill when a generic prescription drug is at ...
The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.
The FDA has approved a new type of painkiller that doesn't come with the risks of addiction and overdose associated with opioids.
The Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for ...
After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the U.S. Food and Drug Administration (FDA) has ...
The FDA has approved Journavx, a new non-opioid pain medication designed to reduce addiction and overdose risks.
Despite high demand for an option like Journavx, doctors fear the drug’s price could be a hangup for insurers and limit ...
A recent study shows that the lack of trust is justified. Your doctor may be ignoring your pain. Here’s what you need to know ...
Research indicates CBD may play a promising complementary role in pain management, though additional clinical trials are necessary. Continue reading to learn about using CBD to curb pain and the ...
The Delhi government's Department of Education (DoE) will release the first merit list for admission to nursery, KG, and Class 1 admissions in private unaided recognised schools on January 17 ...